Publication | Open Access
Semaglutide ameliorates Alzheimer's disease and restores oxytocin in APP/PS1 mice and human brain organoid models
20
Citations
43
References
2024
Year
Semaglutide can ameliorate Alzheimer's disease in pre-clinical models, suggesting the promising therapeutic potential in AD patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1